Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M3,292Revenue $M1,317Net Margin (%)10.6Altman Z-Score2.9
Enterprise Value $M3,882EPS $2.9Operating Margin %14.1Piotroski F-Score8
P/E(ttm)24.0Beneish M-Score-2.8Pre-tax Margin (%)13.4Higher ROA y-yY
Price/Book4.810-y EBITDA Growth Rate %--Quick Ratio2.0Cash flow > EarningsY
Price/Sales2.55-y EBITDA Growth Rate %--Current Ratio2.3Lower Leverage y-yY
Price/Free Cash Flow16.4y-y EBITDA Growth Rate %7.3ROA % (ttm)7.5Higher Current Ratio y-yY
Dividend Yield %--PEG--ROE % (ttm)20.6Less Shares Outstanding y-yY
Payout Ratio %--Shares Outstanding M47.4ROIC % (ttm)11.5Gross Margin Increase y-yY

Gurus Latest Trades with CRL

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
CRLJohn Rogers 2015-06-30 Reduce-0.07%$69.16 - $79.29
($74.08)
$ 70.38-5%Reduce 4.48%1,679,650
CRLDavid Dreman 2015-06-30 Add0.01%$69.16 - $79.29
($74.08)
$ 70.38-5%Add 3.65%58,376
CRLKen Fisher 2015-06-30 Add0.01%$69.16 - $79.29
($74.08)
$ 70.38-5%Add 26.30%508,316
CRLDavid Dreman 2015-03-31 Reduce-0.31%$63.88 - $84.2
($73.77)
$ 70.38-5%Reduce 51.60%56,322
CRLRobert Olstein 2015-03-31 Sold Out -0.25%$63.88 - $84.2
($73.77)
$ 70.38-5%Sold Out0
CRLJohn Rogers 2015-03-31 Reduce-0.18%$63.88 - $84.2
($73.77)
$ 70.38-5%Reduce 12.26%1,758,445
CRLJoel Greenblatt 2015-03-31 Sold Out -0.0021%$63.88 - $84.2
($73.77)
$ 70.38-5%Sold Out0
CRLKen Fisher 2015-03-31 Add$63.88 - $84.2
($73.77)
$ 70.38-5%Add 5.05%402,466
CRLRobert Olstein 2014-12-31 Reduce-0.69%$56.46 - $65.59
($62.72)
$ 70.3812%Reduce 73.55%32,000
CRLJoel Greenblatt 2014-12-31 Buy $56.46 - $65.59
($62.78)
$ 70.3812%New holding4,028
CRLJoel Greenblatt 2014-09-30 Sold Out -0.01%$52.24 - $61.2
($57.34)
$ 70.3823%Sold Out0
CRLRobert Olstein 2014-06-30 Add0.38%$50.74 - $61.47
($54.9)
$ 70.3828%Add 64.20%133,000
CRLDavid Dreman 2014-06-30 Reduce-0.2%$50.74 - $61.47
($54.9)
$ 70.3828%Reduce 27.79%109,870
CRLKen Fisher 2014-06-30 Add0.02%$50.74 - $61.47
($54.9)
$ 70.3828%Add 76.46%371,824
CRLJoel Greenblatt 2014-06-30 Buy 0.01%$50.74 - $61.47
($54.9)
$ 70.3828%New holding11,280
CRLRobert Olstein 2014-03-31 Reduce-0.68%$52.88 - $62.01
($58.09)
$ 70.3821%Reduce 52.07%81,000
CRLJohn Rogers 2014-03-31 Reduce-0.4%$52.88 - $62.01
($58.09)
$ 70.3821%Reduce 23.58%2,009,262
CRLDavid Dreman 2014-03-31 Reduce-0.24%$52.88 - $62.01
($58.09)
$ 70.3821%Reduce 28.25%152,159
CRLJoel Greenblatt 2014-03-31 Sold Out -0.03%$52.88 - $62.01
($58.09)
$ 70.3821%Sold Out0
CRLKen Fisher 2014-03-31 Add0.02%$52.88 - $62.01
($58.03)
$ 70.3821%Add 288.19%210,712
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

CRL is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


CRL: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
ACKERMAN THOMAS FSenior Financial Advisor 2015-08-17Sell5,000$75.53-6.82view
Kochevar Deborah TurnerDirector 2015-08-03Sell6,250$76.69-8.23view
CHUBB STEPHEN DDirector 2015-08-03Sell2,000$76.46-7.95view
ACKERMAN THOMAS FCorporate Executive VP & CFO 2015-05-15Sell1,100$71.06-0.96view
ACKERMAN THOMAS FCorporate Executive VP & CFO 2015-05-15Sell3,900$70.51-0.18view
MASSARO GEORGEDirector 2015-05-07Sell1,360$70.210.24view
CHUBB STEPHEN DDirector 2015-05-01Sell2,000$69.80.83view
Crowley John JSVP, Chief Accounting Officer 2015-03-04Sell912$76.53-8.04view
CHUBB STEPHEN DDirector 2015-03-03Sell2,000$75.52-6.81view
Kochevar Deborah TurnerDirector 2015-03-02Sell2,600$76.59-8.11view

Press Releases about CRL :

Quarterly/Annual Reports about CRL:

    News about CRL:

    Articles On GuruFocus.com
    Carl Appoints Rick Sanderson to the Board of Directors Jun 30 2015 
    Weekly Highlight of CEO Sells Oct 13 2014 
    John Rogers Comments on Charles River Laboratories Intl Inc Jul 22 2014 
    John Rogers' Ariel Fund Second Quarter 2014 Commentary Jul 22 2014 
    Robert Olstein’s Largest New Stock Picks Feb 12 2013 
    Weekly CFO Sells HIGHLIGHT: TMO, BLOX, VRSK, CRL, INGR, GWRE Jan 13 2013 
    Ariel Funds Top Buys: "We think like Halvorsen: CRL is a buy" Jan 11 2012 
    Stocks I Can Buy Much Cheaper Than Halvorsen Did Jan 11 2012 
    Ken Heebner Top Holdings: AAPL Is a Buy at $380 Jan 11 2012 
    Charles River Laboratories International Reports Operating Results (10-Q) Nov 04 2010 

    More From Other Websites
    Charles River Laboratories International, Inc. Earnings Q2, 2015 Aug 28 2015
    CHARLES RIVER LABORATORIES INTERNATIONAL INC Files SEC form 8-K, Change in Directors or Principal... Aug 18 2015
    Credit Suisse Sees Big Biopharma Upside in Top Contract Research Outfits Aug 16 2015
    Jim Cramer's Top Takeaways: WisdomTree Investments, Google, Charles River Labs Aug 12 2015
    Jim Cramer's 'Mad Money' Recap: How to Make Sense of China's Desperate Act Aug 11 2015
    Zacks Investment Ideas feature highlights: INC Research, AMN Healthcare Services, Charles River... Aug 10 2015
    CHARLES RIVER LABORATORIES INTERNATIONAL INC Financials Aug 06 2015
    How Charles River Laboratories International (CRL) Stock Stands Out in a Strong Industry - Tale of... Aug 05 2015
    Intertek Group Plc: Strong price momentum but will it sustain? Aug 04 2015
    10-Q for Charles River Laboratories International, Inc. Aug 01 2015
    Edited Transcript of CRL earnings conference call or presentation 30-Jul-15 12:30pm GMT Jul 30 2015
    Charles River Laboratories International Inc Earnings Call scheduled for 8:30 am ET today Jul 30 2015
    Charles River misses 2Q profit forecasts Jul 30 2015
    Charles River misses 2Q profit forecasts Jul 30 2015
    CHARLES RIVER LABORATORIES INTERNATIONAL INC Files SEC form 8-K, Results of Operations and Financial... Jul 30 2015
    Q2 2015 Charles River Laboratories International Inc Earnings Release - Before Market Open Jul 30 2015
    Charles River Laboratories and AstraZeneca Renew Strategic Partnership Agreement Jul 30 2015
    Charles River Laboratories Announces Second-Quarter 2015 Results from Continuing Operations Jul 30 2015
    Charles River Laboratories Completes the Acquisition of Celsis International Ltd. Jul 24 2015
    Charles River Laboratories (CRL) Stock Downgraded at Barclays Jul 10 2015

    Add Notes, Comments

    If you want to ask a question or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    FEEDBACK